Raymond James & Associates’s M.D.C. Holdings, Inc. MDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-42,012
Closed -$39K 3720
2020
Q2
$39K Hold
42,012
﹤0.01% 3401
2020
Q1
$35K Buy
+42,012
New +$1.47M ﹤0.01% 3354
2019
Q3
Sell
-25,812
Closed -$10K 3741
2019
Q2
$10K Sell
25,812
-432
-2% -$12.7K ﹤0.01% 3587
2019
Q1
$15K Buy
+26,244
New +$695K ﹤0.01% 3548
2018
Q4
Sell
-29,277
Closed -$8K 3727
2018
Q3
$8K Buy
29,277
+117
+0.4% +$3.14K ﹤0.01% 3590
2018
Q2
$9K Buy
+29,160
New +$758K ﹤0.01% 3529

Other funds holding MDC

Raymond James & Associates's MDC Position: Q2 2024 in Review

Raymond James & Associates sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2024, closing a stake of 137,811 shares — an estimated $8.67M sold.

Raymond James & Associates first reported a position in MDC in Q2 2013 and held it in 44 quarters. The position peaked at $49.7M in Q4 2023. 4 funds tracked by Wall St. Rank hold MDC as of Q2 2024.

  • Raymond James & Associates reported no remaining M.D.C. Holdings, Inc. position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 137,811 M.D.C. Holdings, Inc. shares in Q2 2024, an estimated $8.67M.
  • Raymond James & Associates first reported a position in M.D.C. Holdings, Inc. in Q2 2013 and held it in 44 quarters.
  • Raymond James & Associates's M.D.C. Holdings, Inc. position peaked at $49.7M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.